Breaking News, Financial News

Financial Report: Dendreon

Revenues down 18% in the quarter

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Dendreon 1Q Revenues: $67.6 million (-18%) 1Q Loss: $72.0 million (loss of $103.9 million 1Q12) Comments: The company added 33 new accounts for PROVENGE in the quarter, bringing total number to 835. Dendreon anticipates reducing cost of goods sold (COGS) to below 50% of net product revenue in 3Q13....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters